Primary Study End Points of Device Safety and Feasibility Received Positive Results; Majority of Participants Experienced Clinically Meaningful Walking Speed Improvements MARLBOROUGH, Mass., June 22, ...

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 3, 2018 /PRNewswire-USNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic exoskeletons, ...

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals ...

ReWalk Robotics hopes to eventually reach profitability after the U.S. Food & Drug Administration last week approved the ReStore, an exoskeleton system designed to help stroke patients rehab and ...

A new study published in the Journal of NeuroEngineering and Rehabilitation indicates 64% of study participants who experienced stroke-related mobility issues were able to walk significantly faster ...

MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb ...

Shares of ReWalk Robotics Ltd. rocketed 176% in very active premarket trading Wednesday, after the Food and Drug Administration cleared the company's ReStore soft exo-suit system for sale to ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ReWalk Robotics Ltd. (NASDAQ: RWLK) shares absolutely ...

The rise of the robots is making its way to stroke survivors who need help learning how to walk again with a one-of-a-kind soft exo-suit that attaches to the patient’s leg and assists with their gait.

Lifeward selected Verita as its partner in these targeted regions to integrate ReWalk into their multi-modal treatment methodologies for people living with neurological and spinal cord injuries. Today ...